Diabetes Archives

Boehringer Ingelheim Zealand Pharma diabetes

News and Trends 23 Aug 2017

Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs

Boehringer Ingelheim starts two new Phase I trials with drugs intended to treat type 2 diabetes and obesity discovered through a partnership with Danish biotech Zealand. The new Phase I trials initiated by Boehringer Ingelheim will be conducted in Germany, with results expected at the end of 2018. The drugs evaluated will be a long-acting […]

August 23, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Novo Nordisk Semaglutide GLP 1 receptor agonist type 2 diabetes Eli Lilly Trulicity dulaglutide

More News! 18 Aug 2017

Novo Nordisk’s New Type 2 Diabetes Drug Outperforms Eli Lilly’s

Novo Nordisk has reported Phase III data that reveal its candidate semaglutide improved glucose control and weight loss in type 2 diabetes when compared with Eli Lilly’s dulaglutide. The results of the SUSTAIN 7 trial comparing the efficacy of Novo Nordisk’s semaglutide with Eli Lilly’s Trulicity (dulaglutide), already in the market, have revealed that Novo’s […]

August 18, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 9 Aug 2017

Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO

After announcing its intentions last month, Zealand Pharma has gone public in the US to fund its diabetes clinical trials. Zealand Pharma, a Glostrup-based biotech focused on peptide development for diabetes, has been public on the Danish Aktieselskabet exchange since 2011, and since then its share price has risen by 50%. After filing for an American […]

August 9, 2017 - 2 minutesmins - By Evelyn Warner

News and Trends 19 Jul 2017

FREE White Paper! All You need to Know about Omics and Body Fat

What do you think when you hear the word ‘lipid’? I bet your thoughts include fat, energy, hormones, maybe cells? But what if I told you that lipids can also be considered as biomarkers? Very important biomarkers too that can be analyzed and identified using multiparametric statistical analysis! With more and more research focusing on […]

July 19, 2017 - 3 minutesmins - By External Contributor

News and Trends 10 Jul 2017

Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq

Zealand Pharma, known for its partnership with Sanofi to boost the insulin blockbuster Lantus, is aiming high in an IPO on the US Nasdaq. Zealand Pharma has announced it has already filed for an IPO at the Nasdaq Global Select Market, an exclusive listing for large cap companies. Currently listed on the Nasdaq Copenhagen, Zealand Pharma […]

July 10, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Cellnovo type 1 diabetes artificial pancreas

News and Trends 7 Jul 2017

French Mobile Diabetes Firm gets €17.5M to Build an Artificial Pancreas

Cellnovo has launched a capital increase from top European investors to boost its mobile system for diabetes and complete the development of a fully automated artificial pancreas. Cellnovo is a French medtech company with an all-in-one system to manage diabetes in the market. The company has now announced a capital raise of €17.5M to boost […]

July 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 26 Jun 2017

Videos: Who won the Refresh Early-Stage Startup Battle? The Bonsai goes to…

As you might have read in our recap, we had not one but two startup battles for the last edition of Refresh. Watch the companies’ pitches below! Up first was Cambridge Cancer Genomics, which uses AI to design personalised DNA-based tests to help clinicians to better track their patients’ responses to cancer drugs in order to make […]

June 26, 2017 - 2 minutesmins - By Evelyn Warner

type 1 diabetes insulin therapy uppsala university hospital

News and Trends 23 Jun 2017

Diabetic Patients that Still Produce Insulin might be the Key to a New Therapy

A study from Uppsala University has identified higher levels of interleukin-35 in type 1 diabetics that still produce insulin years after their diagnosis. Researchers at Uppsala University have published the first study in humans that shows the potential of interleukin-35 (IL-35) as a promising new target to treat type 1 diabetes. The results, published in […]

June 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Apr 2017

Evotec and Sanofi Hit the First Milestone for a Diabetes Cell Therapy

Evotec and Sanofi have achieved preclinical proof-of-concept for a new beta cell therapy for diabetes, triggering a €3M milestone payment from Sanofi. In 2015, Sanofi and the German CRO Evotec partnered to jointly develop a beta cell replacement therapy for the treatment of diabetes in a deal that could reach more than €300M in potential milestone payments. […]

April 6, 2017 - 2 minutesmins - By Melanie De Almeida

Interview 27 Feb 2017

Meet the Woman developing the Next Generation of Insulin

Fiasp, ultra-fast-acting insulin, could revolutionize insulin. We chatted with Liselotte Hyveled, the woman heading the team behind it. “I didn’t get into nursing school, so I went into pharmacy instead,” Liselotte Hyveled laughs. “In Denmark, we have free education, but the government limits degrees for students based on job market needs. There was a low […]

February 27, 2017 - 7 minutesmins - By Evelyn Warner

News and Trends 30 Jan 2017

Novo Nordisk will open a €135M Diabetes R&D Center at Oxford University

A new research center funded by Novo Nordisk will foster collaborations between its staff and researchers from the University of Oxford. Novo Nordisk and the University of Oxford have announced a collaboration focused on type 2 diabetes research. As part of the effort, the Danish pharma will invest €135M (£115M) over a 10-year period to […]

January 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Screenshot 2017 01 27 at 2.17.05 PM 1 e1485524200727

Startup Scout 27 Jan 2017

Needle-free Treatments for Autoimmune Disorders from Switzerland

It’s back to go back to the mainland. This week’s stop is in Hergiswill, a city by one of the many beautiful seas that can be found in Switzerland. There, the young biotech BioLingus is developing needle-free therapies for chronic diseases. City: Hergiswill, Switzerland Founded: 2014 Employees: 1-10 Financial data: N/A Mission: BioLingus develops non-invasive treatments for autoimmune and inflammatory […]

January 27, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Diabetes

Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs

Novo Nordisk’s New Type 2 Diabetes Drug Outperforms Eli Lilly’s

Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO

FREE White Paper! All You need to Know about Omics and Body Fat

Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq

French Mobile Diabetes Firm gets €17.5M to Build an Artificial Pancreas

Videos: Who won the Refresh Early-Stage Startup Battle? The Bonsai goes to…

Diabetic Patients that Still Produce Insulin might be the Key to a New Therapy

Evotec and Sanofi Hit the First Milestone for a Diabetes Cell Therapy

Meet the Woman developing the Next Generation of Insulin

Novo Nordisk will open a €135M Diabetes R&D Center at Oxford University

Needle-free Treatments for Autoimmune Disorders from Switzerland

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!